Related Experiment Videos
Cardiac transplantation for hypertrophic cardiomyopathy associated with Sengers syndrome
R C Robbins1, D Bernstein, G J Berry
1Department of Cardiothoracic Surgery, Stanford University School of Medicine, California 94305-5247, USA.
Insights
Sengers syndrome, a rare genetic disorder causing cataracts and heart issues, often leads to fatal cardiac failure. This case study details successful cardiac transplantation as a treatment for the associated cardiomyopathy.
Area of Science:
- Genetics and rare diseases
- Cardiology and cardiovascular medicine
- Mitochondrial diseases
Background:
- Sengers syndrome is a rare autosomal recessive disorder.
- It is characterized by congenital cataracts, mitochondrial myopathy, and hypertrophic cardiomyopathy.
- Progressive cardiac failure is the primary cause of mortality.
Observation:
- This report focuses on a patient with Sengers syndrome.
- The patient presented with severe hypertrophic cardiomyopathy.
- The cardiomyopathy significantly contributed to the patient's cardiac dysfunction.
Findings:
- Cardiac transplantation was performed for the treatment of cardiomyopathy in Sengers syndrome.
- The surgical intervention aimed to address the life-threatening cardiac complications.
- This represents a potential therapeutic approach for advanced cases.
Implications:
- Cardiac transplantation may offer a viable treatment option for Sengers syndrome patients with end-stage heart failure.
- Further research is needed to evaluate long-term outcomes and efficacy.
- This case highlights the importance of multidisciplinary management for rare genetic cardiomyopathies.
Abstract:
Sengers' syndrome is a rare condition consisting of congenital cataracts, mitochondrial myopathy, and hypertrophic cardiomyopathy. The syndrome is transmitted in an autosomal recessive pattern. Progressive cardiac failure is the cause of death in most patients. This report describes cardiac transplantation for the treatment of the cardiomyopathy associated with Sengers' syndrome.